Pituitary adenoma and bilateral male breast cancer: An unusual association

Journal of Surgical Oncology

Volumn 64, Issue 1, 1997, Pages 74-78

  Volm, Matthew D ^a   Talamonti, Mark S ^a   Thangavelu, Maya ^a   Gradishar, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

androgen; estrogen; male breast cancer; prolactinoma

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CASE REPORT; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; KLINEFELTER SYNDROME; MALE; MALE BREAST; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

AGED; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; GYNECOMASTIA; HUMANS; MALE; MASTECTOMY, MODIFIED RADICAL; NEOPLASMS, MULTIPLE PRIMARY; PITUITARY NEOPLASMS; PROLACTINOMA; RETROSPECTIVE STUDIES;

EID: 0031052789     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W     Document Type: Article

References (21)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics, 1996. CA Cancer J Clin 1996;6:5-27.
2. Crichlow RW, Galt SW: Male breast cancer. Surg Clin North Am 1990;70:1165-1177.
3. Olsson H, Alm P, Kristoffersson U, Landin-Olsson M: Hypophyseal tumor and gynecomastia preceding bilateral breast cancer development in a man. Cancer 1984;53:1974-1977.
4. Haga S, Watanabe O, Shimizu T, et al.: Breast cancer in a male with prolactinoma. Surg Today 1993;23:251-255.
5. Lee W, Han K, Harris CP, Meisner LF: Detection of aneuploidy and possible deletion in paraffin-embedded rhabdomyosarcoma cells with FISH. Cancer Genet Cytogenet 1993;68:99-103.
6. Thorner MO, Vance ME, Horvath E, Kovacs K: The anterior pituitary. In Wilson JD, Foster DW (eds): "Williams Textbook of Endocrinology," 8th ed. Philadelphia: Saunders, 1992, p 260-268.
7. Braunstein GD: Gynecomastia. N Engl J Med 1993;328:490-495.
8. Sasco AJ, Lowenfels AB, Pasker-deJong P: Review article: epidemiology of male breast cancer: A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-549.
9. Thomas DB: Breast cancer in men. Epidemiol Rev 1993;15:220-231.
10. Calabresi E, DeGiuli G, Becciolini A, et al.: Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 1976;7:605-609.
11. Ribeiro GG, Phillips HV, Skinner LG: Serum oestradiol-17-β, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer. Br J Cancer 1980;41:474-477.
12. Nirmul D, Pegoraro RJ, Jialal I, et al.: The sex hormone profile of male patients with breast cancer. Br J Cancer 1983;48:423-427.
13. Casagrande JT, Hanisch R, Pike MC, et al.: A case-control study of male breast cancer. Cancer Res 1988;48:1326-1330.
14. Rose DP: Endocrine epidemiology of male breast cancer (Review). Anticancer Res 1988;8:845-850.
15. Symmers WS: Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 1968;2:82-85.
16. Pritchard TJ, Pankowsky DA, Crowe JP, Abdul-Karim FW: Breast cancer in a male-to-female transsexual. A case report. JAMA 1988;259:2278-2280.
17. Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: A review. Cancer Res 1977;37:951-963.
18. Meites J: Relation of the neuroendocrine system to the development and growth of experimental mammary tumors. J Neural Transm 1980;48:25-42.
19. Bernstein L, Ross R: Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
20. Olsson H, Rantsam J: Head trauma and exposure to prolactin elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 1988;80:679-683.
21. Olsson H, Alm P, Aspegren K, et al.: Increased prolactin levels in a group of men with breast cancer - a preliminary study. Anticancer Res 1990;10:59-62.